Cancer Research Technology
Log in Register
Menu

E. coli strain ALS1048
NEW

Invented by Mark Eiteman

Info

Catalogue Number 153941
Antigen/Gene or Protein Targets Escherichia coli cells cannot metabolize glucose.
Classification Escherichia coli
Bacterial Resistance N/A
Relevance Microbial fermentation processes are used to generate a myriad of comedic chemicals representing market segments valued in the billions of dollars. Microbial metabolic pathways are not though, naturally optimal for the generation of a desired chemical, rather they have evolved for the benefit of the organism. Metabolic engineering is the targeted and rational alteration of metabolism, and it involves the redirection of intra-cellular processes to generate a new product or a product in much higher yields and/or faster rates. UGA researchers have developed a collection of engineered E. coli strains that are capable of (i) producing pyruvate, (ii) used in the co-fermentation – at the same rate - of mixed pentoses and hexoses, or (iii) reducing the formation of acetate by-product of fermentations, under different metabolic conditions. These strains are optimal starting points for the development of novel derivative strains for industrial use
Genomic Feature MG1655 ΔptsG763::(FRT) ΔmanZ743::(FRT) Δglk-726::(FRT)
Notes Lysogeny broth: 10g/L tryptone, 10g/L NaCl, 5g/L yeast extract, pH adjusted to 7.0, aerobic 37C. Provided as lyophilized culture.
Research Area Metabolism, Microbiology, Bacteriology

References: 1 entry

Eiteman et al. 2009. Biotechnol Bioeng. 102(3):822-7. PMID: 18828178.


Add a reference

References: 1 entry

Eiteman et al. 2009. Biotechnol Bioeng. 102(3):822-7. PMID: 18828178.


Add a reference

References: 1 entry

Eiteman et al. 2009. Biotechnol Bioeng. 102(3):822-7. PMID: 18828178.


Add a reference


This reagent does not have any reviews at the moment.